Navigation Links
Attitudes towards assisted reproduction and preimplantation genetic diagnosis
Date:12/17/2008

ies except Israel (where acceptance is very high), Japan and Spain, with Denmark, Germany, Austria, France and the Netherlands registering the lowest approval scores

  • Finally, the use of in vitro fertilization to choose the sex of a baby provokes outright rejection in all the countries analyzed (mean score below 3 points in every case), with acceptance lowest in Denmark, Sweden, France, the Netherlands and the United Kingdom.

    ATTITUDES TOWARDS PREIMPLANTATION GENETIC DIAGNOSIS

    The application of a genetic test to the embryos obtained from artificial fertilization before they are implanted in the uterus of the future mother is another biomedical advance that brings significant medical benefits but is also a focus of moral controversy.

    Social attitudes towards preimplantation genetic testing depend strongly on the goal being pursued. Some of its main therapeutic indications detection of genetically transmitted diseases and, more recently, the selection of a healthy, compatible embryo that can help cure a brother or sister of a genetic disease deactivate reservations to its use, whereas its possible application in selecting the sex of the future baby activates powerful moral reservations (table 3).

    A large majority of citizens are disposed to accept preimplantation genetic diagnosis:

    • so a couple with serious genetic diseases can select embryos that do not carry the defective gene (mean scores above 6 points in all cases on a scale from 0 to 10, where 0 means totally unacceptable and 10 totally acceptable)

    • so a couple with a child suffering some genetic disease can select embryos that are not affected by the defective gene and conceive a healthy, compatible child that can help cure its brother or sister (mean score likewise exceeding 6 points in almost every country)

    • so any couple can detect whether an embryo carries a gene predisposing it to suffer some grave disease in adultho
      '/>"/>

    Contact: Javier Fernandez
    comunicacion@fbbva.es
    34-913-748-088
    Fundacin BBVA
    Source:Eurekalert

    Page: 1 2 3 4

    Related biology news :

    1. Could genetic research awaken racist attitudes?
    2. BBVA Foundation international study on attitudes to stem cell research
    3. Scientists announce major progress towards historic Census of Marine Life in 2010
    4. Researchers take first steps towards spinal cord reconstruction following injury
    5. Research points towards early cancer detection
    6. Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle
    7. December 2008 highlights from Biology of Reproduction
    8. October 2008 Biology of Reproduction highlights
    9. New master switch found in the brain that regulates appetite and reproduction
    10. Ancient mother spawns new insight on reptile reproduction
    11. September 2008 Biology of Reproduction highlights
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/11/2015)... -- Through a well-rounded UAS delegation representing private industry, government, and ... at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people from ... UAS ecosystem. "Our message is clear and ... Rich Knoll . "If you want to fly UAS, ...
    (Date:5/10/2015)... Fingerprint Cards (FPC) has received an order for ... World Peace Industrial Group (WPI), part of WPG Holdings. WPI ... . Deliveries are planned to take place during Q3 2015 ... China . The order value of 235 ... 1 000 MSEK for 2015.   Jörgen Lantto, acting ...
    (Date:5/7/2015)... Sweden , May 7, 2015 ... touch fingerprint sensors, FPC1022 and FPC1035, FPC,s smallest ... and FPC1035 are mainly considered for integration on ... size gives smartphone OEMs increased possibilities to integrate ... The decreased size also improves possibilities for module ...
    Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
    ... the most common type of lung cancer are notoriously ... to the cellular pathways that regulate responses to cisplatin ... 26th in the journal Cell Reports . The ... to predict how these patients will respond to chemotherapy, ...
    ... Hole Oceanographic Institution (WHOI) researchers have partnered with ... developed at WHOI: the Imaging FlowCytobot, an automated ... that uses light to provide wireless transmission of ... time. WHOI biologists Robert Olson and Heidi ...
    ... University of Leeds and the Chinese Academy of Sciences have ... next generation energy storage systems. Finding more effective and ... deal with the problem of peak demand on electricity grids. ... solar generation is also a pressing problem. People use ...
    Cached Biology News:New biomarker for common lung cancer predicts responses to chemotherapy 2WHOI scientists/engineers partner with companies to market revolutionary new instruments 2WHOI scientists/engineers partner with companies to market revolutionary new instruments 3WHOI scientists/engineers partner with companies to market revolutionary new instruments 4University of Leeds and Chinese Academy of Sciences join forces 2University of Leeds and Chinese Academy of Sciences join forces 3
    (Date:6/1/2015)... , June 1, 2015  Fennec Pharmaceuticals, Inc. ... positive interim results from a poster presented today ... label randomised phase III trial of the efficacy ... patients receiving cisplatin (Cis) monotherapy for standard risk ... American Society of Clinical Oncology (ASCO) 2015 Annual ...
    (Date:6/1/2015)... Minn. and SOUTH SAN FRANCISCO, ... Ventures, the venture arm of Baxter International Inc. (NYSE: ... Development, LLC ("VPD") today announced the formation of Vitesse ... initiated by Baxter Ventures to focus on the development ... immunology, hematology, and oncology. Following the spin-off of Baxter ...
    (Date:6/1/2015)... June 1, 2015 Esperance Pharmaceuticals Inc. today ... lead candidate EP-100 in ovarian cancer patients resistant to ... seek and destroy cancer cells that overexpress luteinizing hormone-releasing ... over-expressed in a wide range of cancers. ... trial of EP-100 were presented at the 2015 ...
    (Date:6/1/2015)... 29, 2015 Research and Markets ... of the "2015 Strategies in European ... their offering. This new 273-page ... diagnostic market, including emerging tests, technologies, instrumentation, ... of leading suppliers. Companies Mentioned: ...
    Breaking Biology Technology:Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 2Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 3Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 5Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
    ... 30, 2011 Current Ceo Rudi Pauwels ... , New Ceo   Appointment Strengthens ... Of Its   First Product In 2013 ... diagnostic (MDx) systems designed to drive personalized medicine and ...
    ... Nov. 30, 2011  DiaTech Life Sciences has announced the ... use of the Microculture Kinetic (MiCK) assay for ... chemotherapy is most effective for cancer patients. DiaTech has ... developed a model to assist pharmaceutical companies in validating ...
    ... today that Lex Van der Ploeg, PhD, has joined ... Ploeg brings to Rhythm more than 25 years of ... therapeutic areas. "Lex has considerable experience with ... are targeting with our ghrelin and melanocortin 4 receptor ...
    Cached Biology Technology:Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer 2Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer 3Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer 4DiaTech Life Sciences Announces Medical Advisory Board 2DiaTech Life Sciences Announces Medical Advisory Board 3Rhythm Names Lex Van der Ploeg Chief Scientific Officer 2
    Request Info...
    Bovine Serum Albumin Peroxidase Stabilizer Solution, 1 L...
    SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
    ... Lysate contains the cellular components necessary for ... elongation and termination factors) but has not ... is used primarily for the isolation of ... of endogenous globin mRNA. Untreated Lysate is ...
    Biology Products: